Microsphere-based once-daily modified release matrix tablets for oral administration in angina pectoris

References

• Amperiadou A, Georgarakis M. Controlled release salbutamol sulphate microcapsules prepared by emulsion solvent-evaporation technique and study on the release affected parameters. Int J Pharm 1995; 115: 1–8
   Web of Science ®Google Scholar
• Bayomi MA, Al-Suwayeh SA, El-heiw AM, Mesnad AF. Preparation of casein-chitosan microspheres containing diltiazem hydrochloride by an aqueous coacervation technique. Pharm Acta Helv 1998; 73: 187–192
   PubMedGoogle Scholar
• Bhalerao SS, Lalla JK, Rane MS. Study of processing parameters influencing the properties of diltiazem hydrochloride microspheres. J Microencapsulation 2001; 18: 299–307
   PubMed Web of Science ®Google Scholar
• Cavallari C, Albertini B, Rodriquez L, Rabasco AM, Fini A. Release of indomethacin from ultrasound dry granules containing lactose-based excipients. J Cont Rel 2005; 102: 39–47
   PubMed Web of Science ®Google Scholar
• Çomoğlu T, Gönül N, Baykara T. The effects of pressure and direct compression on tabletting of microsponges. Int J Pharm 2002; 242: 191–195
   PubMed Web of Science ®Google Scholar
• Das SK, Das NG. Preparation and in vitro dissolution profile of dual polymer (Eudragit®RS100 and RL100) microparticles of diltiazem hydrochloride. J Microencapsulation 1998; 15: 445–452
   PubMed Web of Science ®Google Scholar
• EP. European Pharmacopoeia 5.0. Aubin-France 2005; 233
   Google Scholar
• Halder A, Sa B. Preparation and in-vitro evaluation of polystyrene-coated diltiazem-resin complex by oil-in-water emulsion solvent evaporation method. AAPS PharmSciTech 2006; 7: E1–E8
   Google Scholar
• Hasçiçek C, Gönül N, Erk N. Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: Preparation and in vitro characterization. Il Farmaco 2003; 58: 11–16
   PubMedGoogle Scholar
• Hoffman BB. Therapy of hypertension. The pharmacological basis of therapeutics, 11th ed, Brunton LL, Lazo JS, Parker KL. McGraw-Hill Companies, New York 2006; 845–868
   Google Scholar
• Horoz BB, K·l·çarslan M, Yüksel N, Baykara T. Influence of aluminium tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of Eudragit RS microspheres. AAPS PharmSciTech 2006; 7: E1–E7
   Google Scholar
• Huang H, Ghebre-Sellassie I. Preparation of microspheres of water-soluble pharmaceuticals. J Microencapsulation 1989; 6: 219–225
   PubMed Web of Science ®Google Scholar
• Hutt V, Janik F, Kappler J, Pabst G, Ravelli V, Maccari M, Jaeger H. Evaluation of pharmacokinetics, bioavaliability and dose linearity of diltiazem in healthy volunteers. Arzneimittel-Forschung 1993; 43: 737–743
   PubMed Web of Science ®Google Scholar
• Kakish HF, Tashtoush B, Ibrahim HG, Najib NM. A novel approach for the preparation of highly loaded polymeric controlled release dosage forms of diltiazem HCl and diclofenac sodium. Eur J Pharm Biopharm 2002; 54: 75–81
   PubMedGoogle Scholar
• Kawata M, Nakamura M, Goto S, Aoyama T. Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen. Chem Pharm Bull 1986; 34: 2618–2623
   PubMed Web of Science ®Google Scholar
• Kim CK, Kim MJ, Oh KH. Preparation and evaluation of sustained release microspheres of terbutaline sulfate. Int J Pharm 1994; 106: 213–219
   Web of Science ®Google Scholar
• Kristmundsdóttir T, Gudmundsson ÓS, Ingvarsdóttir K. Release of diltiazem from Eudragit microparticles prepared by spray-drying. Int J Pharm 1996; 137: 159–165
   Web of Science ®Google Scholar
• Mateovic T, Kriznar B, Bogataj M, Mrhar A. The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J Microencapsulation 2002; 19: 29–36
   PubMed Web of Science ®Google Scholar
• Michel T. Treatment of myocardial ischemia. The pharmacological basis of therapeutics, 11th ed, Brunton LL, Lazo JS, Parker KL. McGraw-Hill Companies, New York 2006; 823–844
   Google Scholar
• Obaidat AA, Obaidat RM. Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate. Eur J Pharm Biopharm 2001; 52: 231–235
   PubMed Web of Science ®Google Scholar
• Pather SI, Russell I, Syce JA, Neau SH. Sustained release theophylline tablets by direct compression Part 1: Formulation and in vitro testing. Int J Pharm 1998; 164: 1–10
   Web of Science ®Google Scholar
• Pignatello R, Consoli P, Puglisi G. In vitro release kinetics of Tolmetin from tabletted Eudragit microparticles. J Microencapsulation 2000; 17: 373–383
   PubMed Web of Science ®Google Scholar
• Reddy KR, Mutalik S, Reddy S. Once-daily sustained release matrix tablets of nicorandil: Formulation and in vitro evaluation. AAPS PharmSciTech 2003; 4: 1–9
   Google Scholar
• Schall R, Müller FR, Müller FO, Luus HG. Bioequivalance of controlled-release calcium antagonists. Clin Pharmacokinetics 1997; 32: 75–89
   PubMedGoogle Scholar
• Şengel CT, Hasçiçek C, Gönül N. Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride. J Microencapsulation 2006; 23: 135–152
   PubMed Web of Science ®Google Scholar
• Shimpi S, Chauhan B, Mahadik KR, Paradkar A. Preparation and evaluation of diltiazem HCl-Gelucire 43/01 floating granules prepared by melt granulation. AAPS PharmSciTech 2004; 5: 1–6
   Google Scholar
• Sood A, Pachagnula R. Drug release evaluation of diltiazem CR preparations. Int J Pharm 1998; 175: 95–107
   Web of Science ®Google Scholar
• Souto EB, Mehnert W, Müller RH. Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC. J Microencapsulation 2006; 23: 417–433
   PubMed Web of Science ®Google Scholar
• Sveinsson SJ, Kristmundsdóttir T, Ingvarsdóttir K. The effect of tableting on the release characteristics of naproxen and ibuprofen microcapsules. Int J Pharm 1993; 92: 29–34
   Web of Science ®Google Scholar
• Sweetman SC. Cardiovascular drugs. Martindale the complete drug reference, 33rd ed, Sweetman SC. Pharmaceutical Press, Chicago 2002; 874–877
   Google Scholar
• USP 24/NF 19. 2000. United States of Pharmacopoeia Convention Inc., RockvilleUSA, 574–575
   Google Scholar
• USP 30/NF 25. 2007. United States of Pharmacopoeia Convention Inc., RockvilleUSA, 680–683
   Google Scholar
• Zhang YE, Schwartz JB. Effect of diluents on tablet integrity and controlled drug release. Drug Dev Ind Pharm 2000; 26: 761–765
   PubMed Web of Science ®Google Scholar